Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,919 | 3,194 | 1,783 | 161 | 1,571 |
| Receivables | N/A | N/A | N/A | 13 | 26 |
| Other current assets | 0 | 0 | 0 | 310 | 0 |
| TOTAL | $4,988 | $3,310 | $1,850 | $502 | $1,666 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,988 | $3,310 | $1,850 | $502 | $1,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,114 | 999 | 610 | 1,724 | 940 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1,000 |
| Other current liabilities | 47 | 413 | 586 | 3,300 | 5,872 |
| TOTAL | $1,161 | $1,412 | $1,196 | $5,024 | $7,812 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9 | 9 | 23 | 13 | 9 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,161 | $1,412 | $1,196 | $5,024 | $7,812 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,431 | 941 | 589 | 176 | 109 |
| Common Shares | N/A | N/A | 3 | 1 | 1 |
| Retained earnings | -97,960 | -95,268 | -90,928 | -91,568 | -92,094 |
| Other shareholders' equity | -937 | -938 | -928 | -872 | -810 |
| TOTAL | $3,827 | $1,898 | $654 | $-4,522 | $-6,146 |
| Total Liabilities And Equity | $4,988 | $3,310 | $1,850 | $502 | $1,666 |